Jing Xu

Jing Xu


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 February 2019 in Journal of Translational Medicine
Verified
Journal Article
Open access
PDF file
XHXiaofan Hu
Xiaofan Hu
JXJing Xu
Jing Xu
GCGao Chenni
Gao Chenni
WYWu Yifan
Wu Yifan
YXYu Xialian
Yu Xialian
NCNan Chen
Nan Chen
Patients with Idiopathic membranous nephropathy (IMN) have various outcomes. The aim of this study is to construct a tool for clinicians to precisely predict outcome of IMN. IMN patients diagnosed by renal biopsy from Shanghai Ruijin Hospital from 2009.01 to 2013.12 were enrolled in this study. Primary outcome was defined as a combination of renal function progression [defined as a reduction of estimated glomerular filtration rate (eGFR) equal to or over 30% comparing to baseline], ESRD or death. Risk models were established by Cox proportional hazard regression analysis and validated by bootstrap resampling analysis. ROC curve was applied to test the performance of risk score. Totally 439 patients were recruited in this study. The median follow-up time was 38.73 ± 19.35 months. The enrolled patients were 56 (15–83) years old with a male predominance (sex ratio: male vs female, 1:0.91). The median baseline serum albumin, eGFR-EPI and proteinuria were 23(8–43) g/l, 100.31(12.81–155.98) ml/min/1.73 m2 and 3.98(1.50–22.98) g/24 h, respectively. In total, there were 36 primary outcomes occurred. By Cox regression analysis, the best risk model included age [HR: 1.04(1.003–1.08), 95% CI from bootstrapping: 1.01–1.08), eGFR [HR: 0.97 (0.96–0.99), 95% CI from bootstrapping: 0.96–0.99) and proteinuria [HR: 1.09 (1.01–1.18), 95% CI from bootstrapping: 1.02–1.16). One unit increasing of the risk score based on the best model was associated with 2.57 (1.97–3.36) fold increased risk of combined outcome. The discrimination of this risk score was excellent in predicting combined outcome [C statistics: 0.83, 95% CI 0.76–0.90]. Our study indicated that older IMN patients with lower eGFR and heavier proteinuria at the time of renal biopsy were at a higher risk for adverse outcomes. A risk score based on these three variables provides clinicians with an effective tool for risk stratification.

19 May 2021 in Clinical and Experimental Rheumatology
Verified
Journal Article
Closed access
XAXiao-Ning An
Xiao-Ning An
ZWZhao-Nan Wei
Zhao-Nan Wei
XYXiang-Yun Yao
Xiang-Yun Yao
JXJing Xu
Jing Xu
WQWen-Ting Qian
Wen-Ting Qian
YCYong-Xi Chen
Yong-Xi Chen
Clinical aspects; Authors: X.-N. An, Z.-N. Wei, X.-Y. Yao, J. Xu, W.-T. Qian, X.-X. Pan, P.-Y. Shen, H. Shi, W. Zhang, X.-N. Chen, N. Chen, Y.-X. Chen